Effect of Oral Nitrates on All-Cause Mortality and Hospitalization in Heart Failure Patients with Reduced Ejection Fraction: A Propensity-Matched Analysis


Ural D., Kandemir A., Karauzum K., BAYDEMİR C., Karauzum I. Y., Bozyel S., ...Daha Fazla

JOURNAL OF CARDIAC FAILURE, cilt.23, sa.4, ss.286-292, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1016/j.cardfail.2017.02.006
  • Dergi Adı: JOURNAL OF CARDIAC FAILURE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.286-292
  • Kocaeli Üniversitesi Adresli: Evet

Özet

Background: Hydralazine-nitrate combination is recommended for patients with heart failure with reduced ejection fraction (HFrEF)/systolic heart failure who are symptomatic despite guideline-directed medical therapy (GDMT). Use of nitrates alone for this indication is not well-established. This study aims to evaluate the effect of oral nitrates on all-cause mortality and hospitalization in HFrEF patients using GDMT.